961 related articles for article (PubMed ID: 6197163)
21. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
[TBL] [Abstract][Full Text] [Related]
23. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
24. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Ellis DW; Leffers S; Davies JS; Ng AB
Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
[TBL] [Abstract][Full Text] [Related]
25. Expression of carcinoembryonic or related cross-reacting antigens in primary pediatric neuroectodermal brain tumors.
Bodey B; Siegel SE; Peacock JS
Mod Pathol; 1992 Jul; 5(4):432-8. PubMed ID: 1323111
[TBL] [Abstract][Full Text] [Related]
26. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
Tarle M; Kovacić K; Kastelan M
Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of carcinoembryonic antigens and non cross-reacting antigens in the human thymus. Analysis on frozen sections and cultured epithelial cells using monoclonal antibodies.
Aubry J; Cohen-Kaminsky S; Berrih-Aknin S
Thymus; 1990 Mar; 15(2):107-23. PubMed ID: 2185585
[TBL] [Abstract][Full Text] [Related]
28. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
[TBL] [Abstract][Full Text] [Related]
29. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
[TBL] [Abstract][Full Text] [Related]
30. [Biliary carcinoembryonic antigen, non-specific cross-reacting antigen and biliary glycoprotein--their analysis and clinical aspects].
Yano Y
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1432-42. PubMed ID: 3537682
[TBL] [Abstract][Full Text] [Related]
31. Expression of ras oncogene p21 in prostate cancer.
Viola MV; Fromowitz F; Oravez S; Deb S; Finkel G; Lundy J; Hand P; Thor A; Schlom J
N Engl J Med; 1986 Jan; 314(3):133-7. PubMed ID: 2417118
[TBL] [Abstract][Full Text] [Related]
32. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
33. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
34. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
Frénoy N; Schauffler J; Cahour A; Burtin P
Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
[TBL] [Abstract][Full Text] [Related]
35. [Antigenic structure of NCA-2 from meconium and comparison with normal fecal antigen from adult feces and carcinoembryonic antigen from malignant tissues].
Kuriyama H
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):301-9. PubMed ID: 6201714
[TBL] [Abstract][Full Text] [Related]
36. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
37. [CEA and related antigens as possible new tumor markers].
Matsuoka Y
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
[TBL] [Abstract][Full Text] [Related]
38. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
39. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
40. Control of carcinoembryonic antigen gene family expression in a differentiating colon carcinoma cell line, Caco-2.
Hauck W; Stanners CP
Cancer Res; 1991 Jul; 51(13):3526-33. PubMed ID: 1905198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
